Published in Gastroenterology on February 01, 2001
Portal vein thrombosis; risk factors, clinical presentation and treatment. BMC Gastroenterol (2007) 1.82
Portal vein thrombosis: insight into physiopathology, diagnosis, and treatment. World J Gastroenterol (2010) 1.69
Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut (2005) 1.65
Portal vein thrombosis in adult-onset Still's disease: a case report and literature review. Rheumatol Int (2009) 1.42
Portal hypertension due to portal venous thrombosis: etiology, clinical outcomes. World J Gastroenterol (2007) 1.30
Portal vein thrombosis following laparoscopic sleeve gastrectomy for morbid obesity. JSLS (2013) 1.16
Management of anticoagulation for portal vein thrombosis in individuals with cirrhosis: a systematic review. Int J Hepatol (2012) 1.08
Huge Varicose Inferior Mesenteric Vein: an Unanticipated (99m) Tc-labeled Red Blood Cell Scintigraphy Finding. Nucl Med Mol Imaging (2010) 1.05
Etiology and consequences of thrombosis in abdominal vessels. World J Gastroenterol (2006) 0.99
Portal vein thrombosis in patients with end stage liver disease awaiting liver transplantation: outcome of anticoagulation. Dig Dis Sci (2013) 0.93
Venous thromboembolic disease. J Natl Compr Canc Netw (2011) 0.93
Portal vein thrombosis. J Clin Exp Hepatol (2015) 0.92
Etiology and Complications of Portal Vein Thrombosis. Viszeralmedizin (2014) 0.88
Pregnancy and vascular liver disease. J Clin Exp Hepatol (2015) 0.88
Thrombosis of the portal venous system. J Ultrasound (2007) 0.87
Aetiology of extrahepatic portal vein thrombosis. Gut (2002) 0.87
Portal vein thrombi after ileal pouch-anal anastomosis: its incidence and association with pouchitis. Surg Today (2007) 0.86
Venous thromboembolism in cirrhosis: a review of the literature. Can J Gastroenterol (2012) 0.85
Nonsurgical Therapeutic Options in Portal Vein Thrombosis. Viszeralmedizin (2014) 0.85
Management of acute non-cirrhotic and non-malignant portal vein thrombosis: a systematic review. World J Surg (2011) 0.85
Guidance for the management of venous thrombosis in unusual sites. J Thromb Thrombolysis (2016) 0.81
Portomesenteric Vein Thrombosis After Laparoscopic Sleeve Gastrectomy: 3 Case Reports and a Literature Review. Am J Case Rep (2016) 0.81
Imaging Diagnosis of Splanchnic Venous Thrombosis. Gastroenterol Res Pract (2015) 0.80
Management of acute portomesenteric venous thrombosis induced by protein S deficiency: report of a case. Surg Today (2012) 0.80
Mesenteric venous thrombosis following laparoscopic antireflux surgery. Dig Dis Sci (2006) 0.80
Portal vein thrombosis. Case Rep Vasc Med (2015) 0.78
Portal vein thrombosis after laparoscopic splenectomy: an ongoing clinical challenge. JSLS (2005) 0.77
Pancreatic portal cavernoma in patients with cavernous transformation of the portal vein: MR findings. Eur Radiol (2009) 0.77
Splanchnic venous thrombosis driven by a constitutively activated JAK2 V617F philadelphia-negative myeloproliferative neoplasm: a case report. Afr Health Sci (2014) 0.77
Management of portal vein thrombosis in cirrhotic patients. Mediterr J Hematol Infect Dis (2009) 0.77
Hypoxia-inducible factor 1-α in chronic gastrointestinal ischemia. Virchows Arch (2014) 0.77
JAK2V617F mutation in patients with portal vein thrombosis. Dig Dis Sci (2008) 0.77
Does endothelium agree with the concept of idiopathic hepatic vessel thrombosis? World J Gastroenterol (2006) 0.76
Association of Oesophageal Varices and Splanchnic Vein Thromboses in Patients with JAK2-Positive Myeloproliferative Neoplasms: Presentation of Two Cases and Data from a Retrospective Analysis. Case Rep Oncol (2013) 0.76
Recurrent Thrombotic Events after Discontinuation of Vitamin K Antagonist Treatment for Splanchnic Vein Thrombosis: A Multicenter Retrospective Cohort Study. Gastroenterol Res Pract (2015) 0.76
A sticky situation. BMJ Case Rep (2009) 0.75
Acute Cholecystitis Complicated with Portal Vein Thrombosis: A Case Report and Literature Review. Am J Case Rep (2015) 0.75
Follow-up results of acute portal and splenic vein thrombosis with or without anticoagulation therapy after hepatobiliary and pancreatic surgery. Ann Surg Treat Res (2015) 0.75
Thrombosis of the portal venous system following blunt abdominal trauma. BMJ Case Rep (2010) 0.75
Management of portal vein thrombosis. Gastroenterol Hepatol (N Y) (2008) 0.75
Anticoagulation therapy may reverse biliary abnormalities due to acute portal thrombosis. Dig Dis Sci (2006) 0.75
Thrombotic Venous Diseases of the Liver. J Clin Transl Hepatol (2015) 0.75
Portal Vein Thrombosis due to Prothrombin Gene Mutation following Sleeve Gastrectomy. Case Rep Gastrointest Med (2015) 0.75
Anticoagulation therapy for recent portal vein thrombosis in a patient with liver cirrhosis suffering from variceal rebleeding. Gastroenterology (2002) 0.75
Initial management of noncirrhotic splanchnic vein thrombosis: when is anticoagulation enough? Can J Gastroenterol Hepatol (2014) 0.75
Clinical outcomes of symptomatic arterioportal fistulas after transcatheter arterial embolization. World J Radiol (2013) 0.75
Portal Venous Thrombosis-Disseminated Tuberculosis in Rheumatoid Arthritis. J Clin Diagn Res (2017) 0.75
Portomesenteric vein thrombosis after gastric surgery. Gastric Cancer (2015) 0.75
The Best Anticoagulation Strategy for Cirrhotic Patients who Underwent Splenectomy: A Network Meta-Analysis. Gastroenterol Res Pract (2017) 0.75
Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med (1997) 3.49
Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors. Hepatology (2000) 3.16
Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct. N Engl J Med (2001) 2.95
Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. J Hepatol (2000) 2.68
Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology (1999) 2.63
Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology (1995) 2.54
Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy. Hepatology (2000) 2.34
Hepatocellular carcinoma occurring in nonfibrotic liver: epidemiologic and histopathologic analysis of 80 French cases. Hepatology (2000) 2.21
Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut (2002) 2.21
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*. J Viral Hepat (2011) 2.00
Mechanism of phenobarbital-induced hypercholeresis in the rat. Am J Physiol (1970) 1.99
The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology (2001) 1.87
Second generation (RIBA) test in diagnosis of chronic hepatitis C. Lancet (1991) 1.84
Relationship between alcohol and tobacco dependencies among alcoholics who smoke. Addiction (1995) 1.81
Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med (1985) 1.75
Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry. Am J Transplant (2006) 1.73
The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost (2006) 1.72
Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV. J Infect Dis (1998) 1.72
Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C. Hepatology (1998) 1.69
Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology (1994) 1.69
Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut (2002) 1.68
Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut (2005) 1.65
Assessment of the benefits and risks of percutaneous biopsy before surgical resection of hepatocellular carcinoma. J Hepatol (2001) 1.61
Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4. Gut (2009) 1.56
Common bile duct stricture as a late complication of upper abdominal radiotherapy. J Hepatol (1994) 1.56
Living donor liver transplantation for early hepatocellular carcinoma: A life-expectancy and cost-effectiveness perspective. Hepatology (2001) 1.53
Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections in health care workers (HCWs): guidelines for prevention of transmission of HBV and HCV from HCW to patients. J Clin Virol (2003) 1.53
Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology (2001) 1.51
Hepatitis after intravenous buprenorphine misuse in heroin addicts. J Hepatol (2001) 1.51
Association of hepatic vein obstruction and coeliac disease in North African subjects. J Hepatol (1994) 1.51
Effect of inhibitors of sodium transport on bile formation in the rabbit. Am J Physiol (1970) 1.49
Protein F. A novel F(ab)-binding factor, present in normal liver, and largely released in the digestive tract during hepatitis. J Immunol (1990) 1.47
Acute infusions of bile salts increase biliary excretion of iron in iron-loaded rats. Gastroenterology (1991) 1.46
Expression of NOX1, a superoxide-generating NADPH oxidase, in colon cancer and inflammatory bowel disease. J Pathol (2005) 1.45
Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C. Ann Intern Med (1997) 1.44
Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis. Am J Med (1996) 1.44
Focal sparing in the fatty liver as a sign of an adjacent space-occupying lesion. AJR Am J Roentgenol (1998) 1.44
Focal neurological signs in hepatic encephalopathy in cirrhotic patients: an underestimated entity? Am J Gastroenterol (2001) 1.42
Defect of multidrug-resistance 3 gene expression in a subtype of progressive familial intrahepatic cholestasis. Hepatology (1996) 1.41
[Code of professional ethics in clinical research]. Gastroenterol Clin Biol (2001) 1.39
Hemodynamic, neurohumoral, and metabolic responses to amino acid infusion in patients with cirrhosis. Gastroenterology (1992) 1.39
Hypoprothrombinemia and cefotaxime. Am J Gastroenterol (1990) 1.38
Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology (1999) 1.35
Liver/kidney microsome antibody type 1 and hepatitis C virus infection. Hepatology (1992) 1.32
A simple clinico-histopathological composite scoring system is highly predictive of graft outcomes in marginal donors. Am J Transplant (2008) 1.31
Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone. Gastroenterology (1996) 1.26
New serum markers for the detection of severe acute pancreatitis in humans. Am J Respir Crit Care Med (2001) 1.25
Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology (1995) 1.24
Partial hepatectomy or orthotopic liver transplantation for the treatment of resectable hepatocellular carcinoma? A cost-effectiveness perspective. Hepatology (1998) 1.24
Auxiliary liver transplantation: regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure--a multicenter European study. Hepatology (1996) 1.23
Release of calcium from the endoplasmic reticulum by bile acids in rat liver cells. J Biol Chem (1988) 1.21
Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis. Clin Exp Immunol (1992) 1.21
US-guided percutaneous liver biopsy with plugging of the needle track: a prospective study in 72 high-risk patients. Radiology (1992) 1.19
Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension. Eur J Gastroenterol Hepatol (1999) 1.19
Choledocholithiasis: a prospective study of spontaneous common bile duct stone migration. Gastrointest Endosc (2000) 1.19
Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis. Gut (1986) 1.19
Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection. Aliment Pharmacol Ther (2006) 1.18
Close correlation between beta-catenin gene alterations and nuclear accumulation of the protein in human hepatocellular carcinomas. Oncogene (1999) 1.18
Hepatic vein thrombosis in paroxysmal nocturnal hemoglobinuria. A spectrum from asymptomatic occlusion of hepatic venules to fatal Budd-Chiari syndrome. Gastroenterology (1987) 1.18
Factor V Leiden related Budd-Chiari syndrome. Gut (2001) 1.17
Multiple hepatic mitochondrial DNA deletions suggest premature oxidative aging in alcoholic patients. J Hepatol (1997) 1.16
Characteristics of bile acid-mediated Ca2+ release from permeabilized liver cells and liver microsomes. J Biol Chem (1989) 1.16
Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. J Hepatol (2000) 1.15
Mechanisms and control of secretion of bile water and electrolytes. Gastroenterology (1974) 1.15
Ectopic hepatocellular carcinoma arising in the left chest wall: a long-term follow-up. Eur J Gastroenterol Hepatol (2001) 1.15
Hepatocellular uptake of taurocholate in the dog. J Clin Invest (1975) 1.14
Homozygosity for alanine in the mitochondrial targeting sequence of superoxide dismutase and risk for severe alcoholic liver disease. Gastroenterology (2001) 1.14
Portosystemic shunt in Budd-Chiari syndrome: long-term survival and factors affecting shunt patency in 25 patients in Western countries. Surgery (1994) 1.13
Successful endoscopic obturation of gastric varices with butyl cyanoacrylate. Hepatology (1989) 1.13
The intraportal lymphoid nodule and its environment in chronic active hepatitis C: an immunohistochemical study. Hepatology (1993) 1.12
Persistence of systemic and splanchnic hyperkinetic circulation in liver transplant patients. Hepatology (1993) 1.12
Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C. Gut (2003) 1.11
Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome. J Hepatol (1998) 1.11
Hepatopulmonary syndrome increases the postoperative mortality rate following liver transplantation: a prospective study in 90 patients. Am J Transplant (2006) 1.09
Gene expression and hepatitis C virus infection. Gut (2008) 1.08
Hypercholeresis induced by ursodeoxycholic acid and 7-ketolithocholic acid in the rat: possible role of bicarbonate transport. Gastroenterology (1980) 1.08
AIDS-related cholangitis: diagnostic features and course in 15 patients. J Hepatol (1993) 1.08